OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for osteosarcoma.
OS Therapies has raised $5.3M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2026.
OS Therapies's investors include Noble Capital Markets, K20 Fund, Square Gate Capital, Tichenor Ventures.
OS Therapies is headquartered in Rockville, United States.
OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for osteosarcoma.
OS Therapies is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"OS Therapies — Funding & Investors." VCBacked, April 2, 2026, https://www.vcbacked.co/company/os-therapies. Accessed August 14, 2026.
VCBacked. (2026). OS Therapies — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/os-therapies
{{cite web |title=OS Therapies — Funding & Investors |url=https://www.vcbacked.co/company/os-therapies |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated